R&D
Reducing the stigma attached to psychedelics
It’s no secret that 2023 has been a year for a shift in thinking when …
19777 items found
News
CRUK charts course to solve UK’s poor cancer survival rate
Thousands of people are dying needlessly from cancer in the UK …
R&D
How clinical research is zeroing in on fatty liver disease
Americans’ livers are becoming increasingly unhealthy. In the US, …
News
EVERSANA brings GenAI to medical content approvals
EVERSANA’s alliance with Amazon Web Services (AWS) on the application …
News
Lifeline for Wolman disease kids as NICE backs Alexion drug
Infants with a rare and fatal congenital disorder called Wolman …
News
Dupixent aces second COPD study, setting up FDA filing
With a second positive phase 3 trial in hand, Sanofi and Regeneron …
News
Is GSK’s Blenrep heading for a renaissance?
A year after GSK pulled its BCMA-targeting antibody-drug conjugate …
Patients
‘What If?’ Poetry as a platform for the patient voice
Patient centricity has been a key focus for pharma in 2023. However, …
News
Digital programme improves metabolic health in diabetes
A comprehensive digital approach to helping patients manage type 2 …
News
Experts allay fears over pneumonia outbreak in China
Reports of an outbreak of pneumonia cases among children in China …
R&D
Cultivating quality excellence in the clinical trials landscape
Quality is subjective, with different individuals associating it with …
R&D
Implications of regulatory and FDA guidance on diversity, equity, and inclusion on clinical research study sites
It is well established that focusing on diversity in clinical trials …
R&D
Partner Content
2nd Protein Degradation for CNS Summit | Brand-New Program
Join us at the 2nd Protein Degradation for CNS Summit - an unparalleled event dedicated to delivering protein degraders to undruggable CNS target
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Oncology
Partner Content
9th Tumor Models San Francisco Summit 2025
Implement State-of-the-Art, Reproducible & Predictive in vivo & in vitro Oncology Models to Successfully Identify Promising Targets & Biomarkers, & Surmount the Translationa
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
